Cabozantinib 99%
1 Inquiries
849217-68-1
Pharmaceutical Grade
99%
QINGDAO
10kg/0.12kg Bag
2019-04-25
Dacomitinib
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Cabozantinib
Other Name:1,1-Cyclopropanedicarboxamide,N′-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-;1,1-Cyclopropanedicarboxamide,N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N′-(4-fluorophenyl)-;N′-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide;Cabozantinib;BMS 907351;Cabometyx;1-N-[4-(6,7-Dimethoxyquinolin-4-yl)oxyphenyl]-1-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;XL 184
CAS No.:849217-68-1
Categories:
Hazard IdentificationClassification of the substance or mixture
Skin irritation, Category 2
Serious eye damage, Category 1
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Danger
Hazard statement(s) H315 Causes skin irritation
H318 Causes serious eye damage
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
Response P302+P352 IF ON SKIN: Wash with plenty of water/...
P321 Specific treatment (see ... on this label).
P332+P317 If skin irritation occurs: Get medical help.
P362+P364 Take off contaminated clothing and wash it before reuse.
P305+P354+P338 IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P317 Get medical help.
Storage none
Disposal none
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Dacomitinib
-
Payment Terms:
D/P,L/C
-
Average lead Time:
60
-
Total Annual Revenue:
Less than $1 million
-
Year of Establishment:
2015
Beilang Biology and many well-known universities and scientific research institutions such as Wuhan University, Shanghai University, China Medical University, China Pharmaceutical University, Shenyang Pharmaceutical University, Shanghai Life Science Research Institute, China Institute of Biotechnology, etc. in the research and development of new drugs Cooperation. At the same time, it has extensive cooperation with major pharmaceutical companies such as CSPC, Huayao Group, Lambeau Pharmaceutical, etc. to jointly develop export business. For a long time, colleagues regard Beilang as a long-term reliable partner. We also hope to cooperate more with colleagues in the industry, and move towards a better tomorrow together with the aim of "mutual benefit and mutual growth".
-
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted 
Russia
Cabozantinib
500 KG Nov 19, 2023 Post an enquiry for this product